Crux Biolabs logo — Contract Research Organisation | Specialist Bioanalytical La...

Crux Biolabs

Contract Research Organisation | Specialist Bioanalytical Lab | ISO 17025 for Clinical Trials

Founded 2011 Australia Bayswater, Australia 36 employees Private Equity Biotechnology, Health and Wellness

General Information

Company Name Crux Biolabs
Founded Year 2011
Location Australia Bayswater, Australia
Employees 36
Industries Biotechnology, Health and Wellness
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with Crux Biolabs. To contact Crux Biolabs, visit cruxbiolabs.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Crux Biolabs compare?

A PDF of Crux Biolabs and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Crux Biolabs soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Crux Biolabs

Crux Biolabs is an Australian biotechnology startup, specializing in PBMC processing, pharmacodynamics, and pharmacokinetics for clinical research. The company's ISO 17025 accredited lab in Melbourne offers customized and validated biomarker and cell assays, while their dedicated satellite laboratory in Sydney provides PBMC processing. Founded in 2011, Crux Biolabs prides itself on tailoring its services to meet the unique needs of each study, striving to become an extension of the client's team to ensure the best possible outcome. The recent Private Equity Round investment from Genesis Capital on 04 August 2022 underlines the growing potential and market interest in the company's specialized services, cementing its status as a leader in the field. With its strong focus on high-quality, specialized services and ISO 17025 certification, Crux Biolabs is well-positioned to lead the way in advancing clinical research.

Business keywords: Contract Research Organisation, Bioanalytical Laboratory, ISO 17025, Clinical Trials, Immunology, Oncology, Vaccines, Infectious Diseases, Diabetes, Inflammation, Immunomonitoring, Project Management, ELISA, Flow Cytometry, Pharmacokinetics

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round Undisclosed 1
Genesis Capital
04 Aug 2022

Crux Biolabs Alternatives & Competitors

Crux Biolabs vs

Pioneering the future of immunotherapy through innovative T cell engineering to tackle a diverse arr...

Acquired
12 employees
Biotechnology, Health Care

FAQ About Crux Biolabs

Contract Research Organisation | Specialist Bioanalytical Lab | ISO 17025 for Clinical Trials
Crux Biolabs was founded in 2011.
Crux Biolabs is headquartered in Bayswater, Australia.
Crux Biolabs operates in Biotechnology and Health and Wellness. Its work centres on Contract Research Organisation, Bioanalytical Laboratory, ISO 17025 and Clinical Trials.
Crux Biolabs has approximately 36 employees.
Crux Biolabs has completed 1 funding round. The latest funding stage is Private Equity.
Top alternatives and competitors to Crux Biolabs include Tmunity Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Crux Biolabs and Tmunity Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Crux Biolabs, https://bouncewatch.com/company/crux-biolabs, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes